| Institution: | 1. Klinik und Poliklinik für Onkologie, Universit?ts Spital Zürich, Zürich, Switzerland;2. These authors contributed equally to this study;3. I. Med. Klinik, Saarland University Medical School, Homburg/Saar, Germany;4. Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK;5. Department of Dermatology, University Hospital of Erlangen, Erlangen, Germany;6. Dyax sa, Liège, Belgium;7. Ablynx NV, Zwijnaarde, Belgium;8. Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Switzerland |
